Hikurangi Bioactives is freeing up capital to establish a kānuka industry. Rua Bioscience founder and major shareholder Hikurangi Bioactives has sold nearly half a million more shares in the NZX-listed cannabis company as it plots its next investment. Hikurangi Bioactives Limited Partnership (HBLP) originally owned 100% of Rua Bioscience Ltd and held 16.8% after the company listed on the NZX in a 50c IPO in October. HBLP was subject to full escrow until the company released its first set of half-year results to the NZ, which happened on February 26. At this point, it was able to sell up to 25% of its shareholding, equating to around 5.9m shares. Between March